Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.
- NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_assertion wasGeneratedBy ECO_0000203 NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.
- NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_assertion wasDerivedFrom befree-20150227 NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.
- NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_assertion SIO_000772 23470485 NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.
- NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_assertion evidence source_evidence_literature NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.
- NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_assertion description "[The selectivity of TRAIL towards cancer cells has promoted clinical evaluation of recombinant human TRAIL (rhTRAIL) and its agonistic antibodies in treating several major human cancers including colon and non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.